Boditech Med (206640) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Boditech Med (206640) reported revenue of 162.1 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025162.1 billion KRW28.9 billion KRW23.9 billion KRW[source]
2024138.2 billion KRW26.2 billion KRW27.2 billion KRW[source]
2023134.2 billion KRW28.5 billion KRW26.7 billion KRW[source]
2022118.1 billion KRW24.7 billion KRW25.3 billion KRW[source]
2021157.7 billion KRW51.9 billion KRW47.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025255.4 billion KRW33.0 billion KRW222.4 billion KRW[source]
2024229.9 billion KRW27.8 billion KRW202.1 billion KRW[source]
2023207.8 billion KRW27.7 billion KRW180.0 billion KRW[source]
2022177.1 billion KRW16.5 billion KRW160.6 billion KRW[source]
2021173.1 billion KRW25.0 billion KRW148.1 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
202522.1 billion KRW-48.3 billion KRW-1.8 billion KRW[source]
202424.9 billion KRW-12.0 billion KRW-8.0 billion KRW[source]
202334.3 billion KRW-16.1 billion KRW-1.9 billion KRW[source]
202223.1 billion KRW-24.5 billion KRW-10.2 billion KRW[source]
202149.9 billion KRW-15.6 billion KRW-19.9 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice